loading...
Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Original version developed in 1984
Self-Administered Computerized (SAC BDI-TDI) version was developed in 2004
Mahler DA
Mahler DA, Ward J, Fierro-Carrion G, Waterman LA, Lentine TF, Mejia-Alfaro R, Baird JC. Development of Self-Administered Versions of Modified Baseline and Transition Dyspnea Indexes in COPD. J COPD. 2004; 1:165-172 (Pubmed abstract)
Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93:580-6 (Abstract)
Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85:751-8 (Abstract)
Mahler DA
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
If you do not receive specific funding for your study, you may download the questionnaire directly:
Tutorials are available on our FAQs.
All requests have to be submitted through our online request management:
| ROYALTY FEES* | Commercial users | Cost per study | 1 500 USD (To be paid directly to Dr. Mahler) |
| Cost per language | 1 500 USD (To be paid directly to Dr. Mahler) | ||
| Funded academic research | Cost per study | Free | |
| Cost per language | Free | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
| DISTRIBUTION FEES* | Commercial users | Cost per study | 1 000 € |
| Cost per language | 500 € | ||
| Funded academic research | Cost per study | 300 € | |
| Cost per language | 50 € | ||
| Not funded academic users | Cost per study | Free | |
| Cost per language | Free |
* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds
The Owner, Dr. Mahler Donald A., as defined in section 1.02 may be subject to the laws of the United States including without limitation the United States Affordable Care Act of 2010 and specifically the Physician Payments Sunshine Act (the “US Sunshine Act”). Payments made directly to the Owner may apply as Royalty Fees under the US Sunshine Act if the User is also subject to the laws as a medical device and drug manufacturers (“Applicable Manufacturers”) or group purchasing organizations (“GPOs”) that commercialize the medical device or drug in the USA. The User acknowledges that the User may be required to report the Royalty Fees the appropriate party pursuant to the US Sunshine Act. Please consult www.CMS.gov for more information on the Sunshine Act or contact MRT.
Exclusive licensor for e-versions of the questionnaire: Mapi Research Trust
In case of a one-shot development and commercial use of an electronic version of the questionnaire by the IT Company, the IT Company shall:
www.donaldmahler.com
The vision of this website is to provide information that positively affects the daily lives of those with COPD and their families.
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.
The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
If your study is funded, or if you haven't found your translation in the Languages menu, please submit your request online.
Our team will get back to you as soon as possible.
Handheld
Implemented electronically on TrialMax Touch® home-based devices
Please refer to the "Contact and conditions of use" tab
And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!
A question? Contact us